vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Dayforce (DAY). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($821.5M vs $481.6M, roughly 1.7× Dayforce). Dayforce runs the higher net margin — -40.9% vs -143.3%, a 102.5% gap on every dollar of revenue. On growth, Dayforce posted the faster year-over-year revenue change (9.5% vs 6.1%). Over the past eight quarters, Dayforce's revenue compounded faster (9.8% CAGR vs 3.4%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Dayforce, Inc., formerly Ceridian, is an American human resources software and services company.
ACHC vs DAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $821.5M | $481.6M |
| Net Profit | $-1.2B | $-196.8M |
| Gross Margin | — | — |
| Operating Margin | -142.4% | 6.3% |
| Net Margin | -143.3% | -40.9% |
| Revenue YoY | 6.1% | 9.5% |
| Net Profit YoY | -3710.4% | -9940.0% |
| EPS (diluted) | $-12.98 | $-1.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $821.5M | — | ||
| Q3 25 | $851.6M | $481.6M | ||
| Q2 25 | $869.2M | $464.7M | ||
| Q1 25 | $770.5M | $481.8M | ||
| Q4 24 | $774.2M | $465.2M | ||
| Q3 24 | $815.6M | $440.0M | ||
| Q2 24 | $796.0M | $423.3M | ||
| Q1 24 | $768.1M | $431.5M |
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $36.2M | $-196.8M | ||
| Q2 25 | $30.1M | $21.3M | ||
| Q1 25 | $8.4M | $14.9M | ||
| Q4 24 | $32.6M | $10.8M | ||
| Q3 24 | $68.1M | $2.0M | ||
| Q2 24 | $78.5M | $-1.8M | ||
| Q1 24 | $76.4M | $7.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 47.0% | ||
| Q3 24 | — | 45.8% | ||
| Q2 24 | — | 44.1% | ||
| Q1 24 | — | 47.6% |
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | 6.3% | ||
| Q2 25 | 5.8% | 9.1% | ||
| Q1 25 | 1.7% | 6.4% | ||
| Q4 24 | 4.9% | 6.1% | ||
| Q3 24 | 12.1% | 4.7% | ||
| Q2 24 | 13.4% | 3.3% | ||
| Q1 24 | 12.9% | 9.4% |
| Q4 25 | -143.3% | — | ||
| Q3 25 | 4.3% | -40.9% | ||
| Q2 25 | 3.5% | 4.6% | ||
| Q1 25 | 1.1% | 3.1% | ||
| Q4 24 | 4.2% | 2.3% | ||
| Q3 24 | 8.4% | 0.5% | ||
| Q2 24 | 9.9% | -0.4% | ||
| Q1 24 | 9.9% | 1.6% |
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | $-1.23 | ||
| Q2 25 | $0.33 | $0.13 | ||
| Q1 25 | $0.09 | $0.09 | ||
| Q4 24 | $0.36 | $0.07 | ||
| Q3 24 | $0.74 | $0.01 | ||
| Q2 24 | $0.85 | $-0.01 | ||
| Q1 24 | $0.83 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $133.2M | $627.6M |
| Total DebtLower is stronger | $2.5B | $631.1M |
| Stockholders' EquityBook value | $1.9B | $2.7B |
| Total Assets | $5.5B | $8.7B |
| Debt / EquityLower = less leverage | 1.28× | 0.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | $627.6M | ||
| Q2 25 | $131.4M | $625.2M | ||
| Q1 25 | $91.2M | $557.3M | ||
| Q4 24 | $76.3M | $579.7M | ||
| Q3 24 | $82.1M | $494.1M | ||
| Q2 24 | $77.2M | $465.4M | ||
| Q1 24 | $77.3M | $392.5M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | $631.1M | ||
| Q2 25 | $2.3B | $631.8M | ||
| Q1 25 | $2.2B | $632.4M | ||
| Q4 24 | $2.0B | $1.2B | ||
| Q3 24 | $1.9B | $1.2B | ||
| Q2 24 | $1.8B | $1.2B | ||
| Q1 24 | $1.9B | $1.2B |
| Q4 25 | $1.9B | — | ||
| Q3 25 | $3.1B | $2.7B | ||
| Q2 25 | $3.1B | $2.7B | ||
| Q1 25 | $3.0B | $2.6B | ||
| Q4 24 | $3.1B | $2.5B | ||
| Q3 24 | $3.0B | $2.6B | ||
| Q2 24 | $3.0B | $2.5B | ||
| Q1 24 | $2.9B | $2.4B |
| Q4 25 | $5.5B | — | ||
| Q3 25 | $6.4B | $8.7B | ||
| Q2 25 | $6.3B | $8.5B | ||
| Q1 25 | $6.1B | $9.5B | ||
| Q4 24 | $6.0B | $9.1B | ||
| Q3 24 | $5.9B | $8.1B | ||
| Q2 24 | $5.7B | $9.0B | ||
| Q1 24 | $5.5B | $10.8B |
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | 0.23× | ||
| Q2 25 | 0.74× | 0.23× | ||
| Q1 25 | 0.72× | 0.24× | ||
| Q4 24 | 0.64× | 0.47× | ||
| Q3 24 | 0.62× | 0.47× | ||
| Q2 24 | 0.62× | 0.49× | ||
| Q1 24 | 0.65× | 0.50× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-86.3M | $31.2M |
| Free Cash FlowOCF − Capex | $-179.5M | — |
| FCF MarginFCF / Revenue | -21.8% | — |
| Capex IntensityCapex / Revenue | 11.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-439.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | $31.2M | ||
| Q2 25 | $133.5M | $112.7M | ||
| Q1 25 | $11.5M | $49.6M | ||
| Q4 24 | $116.7M | $81.0M | ||
| Q3 24 | $163.1M | $91.8M | ||
| Q2 24 | $171.1M | $99.2M | ||
| Q1 24 | $-321.3M | $9.1M |
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — | ||
| Q1 24 | $-463.7M | — |
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -60.4% | — |
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — | ||
| Q1 24 | 18.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | 5.29× | ||
| Q1 25 | 1.37× | 3.33× | ||
| Q4 24 | 3.58× | 7.50× | ||
| Q3 24 | 2.39× | 45.90× | ||
| Q2 24 | 2.18× | — | ||
| Q1 24 | -4.21× | 1.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
DAY
| Dayforce Recurring | $333.0M | 69% |
| Cloud And Bureau Professional Services And Other | $78.5M | 16% |
| Float | $42.2M | 9% |
| Powerpay Recurring | $19.7M | 4% |
| Other Recurring | $8.2M | 2% |
